LBG’s Georgia Sloboda was recently recognized by The Corporate Magazine
Georgia Sloboda, Managing Director, CMC at LBG was recently recognized by The Corporate Magazine for her leadership expertise.
News
Dan Vest Discusses OCIs and the Impact of New Legislation in Newly Published Article
Written by LBG’s Dan Vest, “Avoiding Conflicts of Interest,” was recently published in Contract Management magazine. The article focuses on new legislation regarding Organizational Conflicts of Interest (OCIs), which was …
LBG Team Members Engage with the Region’s Innovation Ecosystem to Discuss New Technologies and Advancements in the Life Sciences
Innovations that are shaping the future of bioscience, engineering, and digital technology take front and center at the Innovation Festival, presented by BioKansas, on August 3 – 5 in Kansas …
LBG’s Dan Vest Engages with Contract Management, Acquisition, and Procurement Professionals
The contracting future with AI, FAR/DFARS regulatory updates, and the applicability of federal requirements on nonprofits, state, and local governments are a few trending topics that LBG’s Dan Vest looks …
Ivan Silva Engages with the Global Laboratory Medicine Community
Clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of laboratory medicine are just a few key topics of discussion at the 2023 AACC Annual Scientific …
Robert Huebner Appointed to Missouri Biotechnology Association Board of Directors
Robert Huebner, Ph.D. was recently appointed to the Missouri Biotechnology Association (MOBIO) Board of Directors. The MOBIO Board of Directors assists and helps guide MOBIO leadership by promoting the enrichment …
LBG Awarded Grant to Develop a Global Health Cost Model Platform
LBG was recently awarded a grant by the Bill & Melinda Gates Foundation to develop an easy-to-use, web-based modeling tool for use in determining the cost of goods of pharmaceutical …
LBG Team Members Discuss Quality Requirements During Product Development in Newly Published Article
Written by LBG’s Lauren Schoukroun-Barnes, Ph.D., Dianne Cantara, Sarah DeDonder, Ph.D., and Dawn Speidel, “Pharmaceutical Manufacturing Quality Assurance Programs: Transitioning from Research and Development to the Clinic” was recently published in BioProcess International. The article …
LBG Engages with Thought Leaders and Experts to Advance Global Biotech Industry
Therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital are just a few of the trending topics of discussion at the BIO International Convention. LBG Partners …
Jim Beltzer and Joe Rininger Join Effort to Transform Medicine Through the Use of Cell and Gene Therapies
The record number of gene, gene-modified cell therapies since last year and the recent approval of Gamida Cell’s Omisirge off-the-shelf allogeneic therapy raises an important question: How are other advanced …
